115 related articles for article (PubMed ID: 36959778)
41. Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial.
Oyalowo A; Forde KA; Lamanna A; Kochman ML
JAMA Netw Open; 2022 Mar; 5(3):e224529. PubMed ID: 35357457
[TBL] [Abstract][Full Text] [Related]
42. State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.
Ahluwalia IB; Mack KA; Murphy W; Mokdad AH; Bales VS
MMWR Surveill Summ; 2003 Aug; 52(8):1-80. PubMed ID: 14532868
[TBL] [Abstract][Full Text] [Related]
43. US hysterectomy prevalence by age, race and ethnicity from BRFSS and NHIS: implications for analyses of cervical and uterine cancer rates.
Adam EE; White MC; Saraiya M
Cancer Causes Control; 2022 Jan; 33(1):161-166. PubMed ID: 34546462
[TBL] [Abstract][Full Text] [Related]
44. Racial/Ethnic Disparity in the Relationship of Mental and Physical Health With Colorectal Cancer Screening Utilization Among Breast and Prostate Cancer Survivors.
Tsai MH; Bevel MS; Andrzejak SE
JCO Oncol Pract; 2023 May; 19(5):e714-e724. PubMed ID: 36800561
[TBL] [Abstract][Full Text] [Related]
45. Changes in Cancer Screening in the US During the COVID-19 Pandemic.
Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A
JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622
[TBL] [Abstract][Full Text] [Related]
46. Risk Factors Associated With Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US.
Nianogo RA; Rosenwohl-Mack A; Yaffe K; Carrasco A; Hoffmann CM; Barnes DE
JAMA Neurol; 2022 Jun; 79(6):584-591. PubMed ID: 35532912
[TBL] [Abstract][Full Text] [Related]
47. Colorectal cancer screening disparities for rural minorities in the United States.
Cole AM; Jackson JE; Doescher M
J Prim Care Community Health; 2013 Apr; 4(2):106-11. PubMed ID: 23799717
[TBL] [Abstract][Full Text] [Related]
48. Racial and Ethnic Disparities in Early-Onset Colorectal Cancer Survival.
Zaki TA; Liang PS; May FP; Murphy CC
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):497-506.e3. PubMed ID: 35716905
[TBL] [Abstract][Full Text] [Related]
49. Determinants of cancer screening in Asian-Americans.
Trinh QD; Li H; Meyer CP; Hanske J; Choueiri TK; Reznor G; Lipsitz SR; Kibel AS; Han PK; Nguyen PL; Menon M; Sammon JD
Cancer Causes Control; 2016 Aug; 27(8):989-98. PubMed ID: 27372292
[TBL] [Abstract][Full Text] [Related]
50. Barriers to colorectal cancer screening: physician and general population perspectives, New Mexico, 2006.
Hoffman RM; Rhyne RL; Helitzer DL; Stone SN; Sussman AL; Bruggeman EE; Viera R; Warner TD
Prev Chronic Dis; 2011 Mar; 8(2):A35. PubMed ID: 21324249
[TBL] [Abstract][Full Text] [Related]
51. Effect of Combined Patient Decision Aid and Patient Navigation vs Usual Care for Colorectal Cancer Screening in a Vulnerable Patient Population: A Randomized Clinical Trial.
Reuland DS; Brenner AT; Hoffman R; McWilliams A; Rhyne RL; Getrich C; Tapp H; Weaver MA; Callan D; Cubillos L; Urquieta de Hernandez B; Pignone MP
JAMA Intern Med; 2017 Jul; 177(7):967-974. PubMed ID: 28505217
[TBL] [Abstract][Full Text] [Related]
52. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement.
White A; Vernon SW; Franzini L; Du XL
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):811-7. PubMed ID: 21546366
[TBL] [Abstract][Full Text] [Related]
53. Disparities in Colorectal Cancer Screening Practices in a Midwest Urban Safety-Net Healthcare System.
Elangovan A; Skeans J; Lalani I; Ullah F; Roy A; Kaelber DC; Cooper GS; Sandhu DS
Dig Dis Sci; 2021 Aug; 66(8):2585-2594. PubMed ID: 32816217
[TBL] [Abstract][Full Text] [Related]
54. Surveillance of colorectal cancer screening in new Mexico hispanics and non-Hispanic whites.
Gonzales M; Nelson H; Rhyne RL; Stone SN; Hoffman RM
J Community Health; 2012 Dec; 37(6):1279-88. PubMed ID: 22544418
[TBL] [Abstract][Full Text] [Related]
55. Socioeconomic status and colorectal cancer screening behaviors in a vulnerable multiethnic population.
Santiago-Rodríguez EJ; Rivadeneira NA; Torres JM; Sarkar U; Hiatt RA
Ethn Health; 2022 May; 27(4):980-996. PubMed ID: 33121258
[TBL] [Abstract][Full Text] [Related]
56. The relationship of cancer history and chronic disease status to colorectal cancer screening: A cross-sectional analysis of 2020-2021 Behavioral Risk Factor Surveillance System.
Tsai MH; Lee AW; Lee M
Cancer Causes Control; 2024 Apr; 35(4):623-633. PubMed ID: 37989813
[TBL] [Abstract][Full Text] [Related]
57. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
58. Incident colorectal cancer screening and associated healthcare resource utilization and Medicare cost among Medicare beneficiaries aged 66-75 years in 2016-2018.
Li S; Miller-Wilson LA; Guo H; Hoover M; Fisher DA
BMC Health Serv Res; 2022 Oct; 22(1):1228. PubMed ID: 36192728
[TBL] [Abstract][Full Text] [Related]
59. Colorectal Cancer in Young African Americans: Is It Time to Revisit Guidelines and Prevention?
Ashktorab H; Vilmenay K; Brim H; Laiyemo AO; Kibreab A; Nouraie M
Dig Dis Sci; 2016 Oct; 61(10):3026-3030. PubMed ID: 27278956
[TBL] [Abstract][Full Text] [Related]
60. Rural-urban differences in breast and colorectal cancer screening among US women, 2014-2019.
Theodoropoulos N; Xie H; Wang Q; Wen C; Li Y
Rural Remote Health; 2022 Sep; 22(3):7339. PubMed ID: 36088935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
